Herpes zoster
101 Herpes zoster Rana Majd Mays, Erik T. Petersen, Rachel A. Gordon and Stephen K. Tyring Evidence Levels: A Double-blind study B Clinical trial ≥ 20 subjects C Clinical trial < 20 subjects D…
101 Herpes zoster Rana Majd Mays, Erik T. Petersen, Rachel A. Gordon and Stephen K. Tyring Evidence Levels: A Double-blind study B Clinical trial ≥ 20 subjects C Clinical trial < 20 subjects D…
132 Linear IgA bullous dermatosis Neil J. Korman Evidence Levels: A Double-blind study B Clinical trial ≥ 20 subjects C Clinical trial < 20 subjects D Series ≥ 5 subjects E Anecdotal case reports Linear…
192 Porphyria cutanea tarda Maureen B. Poh-Fitzpatrick Evidence Levels: A Double-blind study B Clinical trial ≥ 20 subjects C Clinical trial < 20 subjects D Series ≥ 5 subjects E Anecdotal case reports The term…
202 Pseudoxanthoma elasticum Kenneth H. Neldner and Mark G. Lebwohl Evidence Levels: A Double-blind study B Clinical trial ≥ 20 subjects C Clinical trial < 20 subjects D Series ≥ 5 subjects E Anecdotal case…
222 Squamous cell carcinoma Jason J. Emer and Heidi A. Waldorf Evidence Levels: A Double-blind study B Clinical trial ≥ 20 subjects C Clinical trial < 20 subjects D Series ≥ 5 subjects E Anecdotal…
191 Porokeratoses Agustin Martin-Clavijo and John Berth-Jones Evidence Levels: A Double-blind study B Clinical trial ≥ 20 subjects C Clinical trial < 20 subjects D Series ≥ 5 subjects E Anecdotal case reports The porokeratoses…
251 Yellow nail syndrome Robert L. Baran Evidence Levels: A Double-blind study B Clinical trial ≥ 20 subjects C Clinical trial < 20 subjects D Series ≥ 5 subjects E Anecdotal case reports The yellow…
122 Leishmaniasis Suhail M. Hadi and Ahmed S. Hadi Evidence Levels: A Double-blind study B Clinical trial ≥ 20 subjects C Clinical trial < 20 subjects D Series ≥ 5 subjects E Anecdotal case reports…
100 Herpes labialis Jane C. Sterling Evidence Levels: A Double-blind study B Clinical trial ≥ 20 subjects C Clinical trial < 20 subjects D Series ≥ 5 subjects E Anecdotal case reports Herpes simplex virus…
98 Hereditary hemorrhagic telangiectasia Mitchell S. Cappell and Oscar Lebwohl Evidence Levels: A Double-blind study B Clinical trial ≥ 20 subjects C Clinical trial < 20 subjects D Series ≥ 5 subjects E Anecdotal case…